Grand Shuyang Life Sciences (Chengdu) Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Grand Shuyang Life Sciences (Chengdu) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia (NCT07233213) | Grand Shuyang Life Sciences (Chengdu) Co., Ltd. | 2025-11-24 |
Track Grand Shuyang Life Sciences (Chengdu) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.